CVS Health-CVS Q2 Estimates Dip: Is the Stock Still a Buy Ahead of Q2 Earnings?

Key Takeaways CVS is expected to post Q2 earnings of $1.47 per share, down 19.67% year over year. Earnings estimates dropped 11 cents over 90 days due to legal, cost and regulatory headwinds. Aetna redesigns and PBM savings efforts are expected to support segment-level Q2 performance.CVS Health Corporation (CVS) is scheduled to report second-quarter 2025 results on July 31, before the opening bell.In the last reported quarter, the company’s adjusted earnings of$ 2.25 exceeded the Zacks Consensus Estimate ...